Previous 10 | Next 10 |
home / stock / thc / thc articles
The cannabis industry may be on the brink of a significant transformation with the advent of triploid cannabis plants. Forbes reports that this new...
New York Regulators Intend To Approve Over 100 Cannabis Licenses In Anticipation Of Weed Sales At Madison Square Garden New York’s cannabis r...
Last week, a measure that would make the sale of all Delta-8, Delta-10, THC-O, HHC and THC-P products and other unregulated THC products illegal ad...
U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Thursday. Shares of Eaton Corporation plc (NYSE: ETN) rose sharply during...
In a recent study published in Sports Medicine, researchers from the University of Colorado delved into the intricate relationship between cannabis...
The Drug Enforcement Administration (DEA) is proposing the production of higher amounts of THC, psilocybin and DMR for research in 2024. In a&...
U.S. Congressman Larry Bucshon (R-IN) says marijuana should be rescheduled under federal law to free up research that could inform the develop...
In an exclusive interview with Benzinga, Dr. Shane Johnson, MD, senior vice president and general manager of BayMedica, sheds light on the company&...
The Georgia Access to Medical Cannabis Commission (GMCC) recently convened a special meeting to discuss the ramifications of warning letters receiv...
News, Short Squeeze, Breakout and More Instantly...
Tenet Healthcare Corporation Company Name:
THC Stock Symbol:
NYSE Market:
Tenet Healthcare Corporation Website:
2024-07-19 10:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-10 07:00:09 ET Andrew Mok from Barclays issued a price target of $156.00 for THC on 2024-07-10 05:58:00. The adjusted price target was set to $156.00. At the time of the announcement, THC was trading at $130.97. The overall price target consensus is at $115.60 wi...